NHS Framework Agreement for the supply of Medical Retinal Vascular Treatments
A Contract Award Notice
by NHS ENGLAND
- Source
- Contracts Finder
- Type
- Framework (Products)
- Duration
- 1 year
- Value
- £450K
- Sector
- HEALTH
- Published
- 07 Sep 2022
- Delivery
- 01 Aug 2022 to 31 Jul 2023
- Deadline
- 06 Apr 2022 17:00
Concepts
Location
Geochart for 1 buyers and 6 suppliers
1 buyer
- NHS England London
6 suppliers
- Teva Castepoint
- Bayer Reading
- Novartis Pharmaceuticals London
- Alimera Sciences Aldershot
- Abbvie Maidenhead
- Roche Products Welwyn Garden City
Description
The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England.
Award Detail
1 | Teva (Castepoint)
|
2 | Bayer (Reading)
|
3 | Novartis Pharmaceuticals (London)
|
4 | Alimera Sciences (Aldershot)
|
5 | Abbvie (Maidenhead)
|
6 | Roche Products (Welwyn Garden City)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Contract is suitable for SMEs.
Reference
- CF-0900100D0O000000rwimUAA
- CF acb80414-da6a-4a87-b1d3-fda017b0e823